Latest updates for Medicare Drug Negotiations

Fresh curated links around Medicare drug negotiations are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Medicare Drug Price Negotiation is here to stay
  • Pharma Companies Want to Block Medicare Drug Discounts. Supreme Court Weighs In
  • 4 High-Use Drugs That Will Have Lower Medicare Prices — And 3 Others Facing Negotiations

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

healthcare-economist.com /1 week ago

Medicare Drug Price Negotiation is here to stay

At least, it won’t be overturned by the US Supreme Court. Endpoints reports: The Supreme Court says it won’t wade into the pharma industry’s yearslong legal battle over Medicare dr...

Read source
moneytalksnews.com /1 week ago

Pharma Companies Want to Block Medicare Drug Discounts. Supreme Court Weighs In

The Supreme Court refused to block Medicare's drug price negotiations, preserving more than 50% out-of-pocket savings for seniors on 10 widely used medications.

Read source
savingadvice.com /2 weeks ago

4 High-Use Drugs That Will Have Lower Medicare Prices — And 3 Others Facing Negotiations

Millions of seniors are finally seeing relief from some of the highest prescription drug costs in America as Medicare’s new drug price negotiation program begins...

Read source
savingadvice.com /1 month ago

Medicare Negotiation Update: 4 Drugs Facing Price Cuts of Up to 50% Under the New Program

Prescription drug costs have long been one of the biggest financial stressors for older Americans. Now, a major shift is finally underway, and it could...

Read source
natlawreview.com /1 week ago

Supreme Court Turns Away First Wave of Negotiation Program Challenges

What Happened? On May 18, the Supreme Court denied all six petitions for certiorari filed by drug manufacturers challenging the IRA’s Medicare Drug Price Negotiation Program, bring...

Read source
savingadvice.com /1 week ago

Medicare Negotiations Continue: 15 More Drugs Including Weight-Loss Treatments Could See Price Cuts in 2027

Prescription drug costs continue to be one of the biggest financial pressures facing retirees and older Americans. In fact, many Medicare beneficiaries (around 21%) spend...

Read source
jdsupra.com /1 day ago

Healthcare Authority Newsletter - May 2026 #3

News Briefs - High Court Won't Hear Drug Manufacturer Price Negotiation Appeal - The Supreme Court declined to hear an appeal from six drug manufacturers that wanted the court to r...

Read source
localnews8.com /1 week ago

Supreme Court rejects Big Pharma appeals challenging negotiated drug prices in Medicare

By John Fritze, Tami Luhby, CNN (CNN) — The US Supreme Court on Monday rejected a series of appeals from several of the nation’s largest drugmakers challenging a program that is ex...

Read source
aha.org /3 weeks ago

CMS to provide Medicare Part D beneficiaries with $50 monthly access to certain GLP-1 medications

The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible Medicare Part D...

Read source
valawyersweekly.com /1 week ago

US Supreme Court rebuffs pharma challenge to Biden-era drug price

The U.S. Supreme Court declined to hear pharmaceutical companies' challenge to the Biden administration's Medicare drug price negotiation plan. The post US Supreme Court rebuffs ph...

Read source
pharmexec.com /1 month ago

<![CDATA[Asembia AXS26: The Battle for Drug Prices Ahead of the Midterms]]>

Read source
moneytalksnews.com /1 month ago

7 Catches in Medicare’s New $50 Weight-Loss Drug Deal

Medicare will cover GLP-1s for $50 starting in July — but the fine print could leave millions of seniors empty-handed.

Read source
navytimes.com /3 weeks ago

Lawmakers introduce bill to lower drug costs for service members, veterans

The proposal would allow Tricare beneficiaries and VA patients to pay the lowest government-negotiated price for prescription drugs.

Read source
moneytalksnews.com /1 month ago

GLP-1 Weight-Loss Drugs Will Still Be Cheap with Medicare, but There’s a Catch

Major insurers including Aetna and UnitedHealth walked away from Medicare's original GLP-1 coverage plan — but a $50-a-month bridge program kicks in July 1 to keep the drugs within...

Read source
moneytalksnews.com /1 month ago

White House to Announce Drug Pricing Deal with Regeneron

Regeneron becomes the last of 17 major drugmakers to sign on, but the secret terms and cash-only focus leave millions of insured Americans wondering what — if anything — changes fo...

Read source
drugs.com /3 weeks ago

A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know

FRIDAY, May 8, 2026 (Health Day News) — Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for M...

Read source
aha.org /1 month ago

White House announces MFN agreement with drug manufacturer Regeneron

The administration Apri 23 reached a most-favored-nation drug pricing agreement with Regeneron, the maker of the popular cholesterol medicine Praluent. This is the 17th such agreem...

Read source
cbsnews.com /3 weeks ago

Are the Trump administration's efforts to lower drug costs working?

President Trump has made cutting drug prices a centerpiece of his second term. He's announced deals with major drug companies and launched TrumpRx, where cash-paying patients could...

Read source
fiercehealthcare.com /1 week ago

White House adds 600 generic meds to TrumpRx purchasing portal

With questions already swirling about the actual affordability impact of the government’s drug purchasing portal TrumpRx, the White House is updating the platform to address a key...

Read source
pbs.org /3 weeks ago

White House says Trump's deals with pharmaceutical companies offer billions in savings

WASHINGTON (AP) — White House economists estimate that President Donald Trump's deals with pharmaceutical companies to drop some of their U.S. prescription drug prices to what they...

Read source
fiercehealthcare.com /1 week ago

OIG: Jury still out on impacts of vertical consolidation in Part D

A new analysis from the Office of Inspector General found a similar net cost for drugs through vertically-integrated Part D plans compared to other plans.

Read source
nbcdfw.com /1 month ago

Drugmakers raised prices on hundreds of drugs despite Trump deals, report finds

President Donald Trump has repeatedly said his deals with drugmakers would bring down prescription drug prices in the U.S. But a report released by Senate Democrats finds prices ha...

Read source
columbian.com /1 month ago

Medicare to pay cost of GLP-1 drugs for seniors

The federal government has scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting instead to pay for the medicine with taxpayer dolla...

Read source
fiercehealthcare.com /1 month ago

Humana's CenterWell, Mark Cuban Cost Plus Drugs partner to tackle employers' drug costs

The arrangement aims to create new "end-to-end employer prescription solutions" fueled by Cost Plus Drugs' software platform and drug pricing, as well as CenterWell Pharmacy's dist...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Medicare Drug Negotiations

localnews8.com

Recent coverage from public sources
Public source

valawyersweekly.com

Recent coverage from public sources
Public source

aha.org

Recent coverage from public sources
Public source

cbsnews.com

Recent coverage from public sources
Public source

columbian.com

Recent coverage from public sources
Public source

drugs.com

Recent coverage from public sources
Public source